Hairy cell leukemia with isolated bone lesions
Laura Cailly1, Cécile Gruchet1, Elsa Maitre2
1Department of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Clinical Case Reports
|May 19, 2023
Summary
Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is crucial for diagnosing and monitoring Hairy Cell Leukemia (HCL), particularly for bone involvement and atypical cases. This imaging technique aids in managing patients with HCL, especially when bone lesions are present.
Area of Science:
- Hematology
- Nuclear Medicine
- Oncology
Background:
- Hairy Cell Leukemia (HCL) is a rare B-cell leukemia.
- Bone involvement is an uncommon but significant manifestation of HCL.
- Standard diagnostic and monitoring tools may underestimate bone lesions in HCL.


